Article Text

Download PDFPDF

Increased intestinal permeability in ankylosing spondylitis--primary lesion or drug effect?
  1. A J Morris,
  2. C W Howden,
  3. C Robertson,
  4. A Duncan,
  5. H Torley,
  6. R D Sturrock,
  7. R I Russell
  1. Gastroenterology Unit, Glasgow Royal Infirmary.


    We have found increased small intestinal permeability to 51Cr-ethylenediaminetetra acetate in patients with ankylosing spondylitis compared with controls. There is no significant difference between patients with ankylosing spondylitis and patients with rheumatoid arthritis taking non-steroidal anti-inflammatory drugs (NSAID). The increased intestinal permeability in ankylosing spondylitis is independent of disease activity. These findings suggest that the increased permeability is caused by NSAID treatment and is probably not a primary lesion of small bowel mucosa.

    Statistics from

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Linked Articles